Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Doctoral Foreign Study Award (DFSA)

Direct Payment

$105,000.00

The Effects of PINK1 Mutations on Mitochondrial Function in Patient Inducible Pluripotent Stem Cell-Derived Dopaminergic Neurons

FY 2011-12

Summary
Parkinson's disease, PD, is a debilitating and incurable neurodegenerative disease that is particularly prevalent amongst the elderly here, in North America. In PD, a specific set of brain cells die. This causes severely impaired movement control in patients. Although the mechanism through which cells die is not fully understood, cellular metabolism has been widely implicated. A particular form of PD, called familial or early-onset PD, is a hereditary form of the disease that can be attributed to mutations in specific genes. Studying these mutants is essential to improve our understanding of PD as a whole. The loss of one protein, called PTEN-induced putative kinase 1, PINK1, is well known to cause early-onset forms of PD. Furthermore, this protein has been implicated in cellular metabolism, though how PINK1 contributes to this remains unknown. The reason that this question still remains unanswered can probably be attributed to the lack of good PD models. Neither animal models nor cells from other organs than the brain can fully recapitulate what occurs in human brain cells. However, recent advances in cell engineering now allow us to make human brain cells from skin cells harvested from PD patients. This provides us with a model in which to study PD that is much more relevant to what occurs in the human brain. Therefore, we will use this exciting new model to study defects in energy production and cellular metabolism in cells from patients lacking PINK1. By studying engineered human brain cells that lack PINK1, we expect to better our understanding of the metabolic defects that occur in PD and, ultimately, contribute to the development of better treatments for PD patients.
Program
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Location
Maryland, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
258476
Name
Scarffe Leslie
Region
Maryland
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The Effects of PINK1 Mutations on Mitochondrial Function in Patient Inducible Pluripotent Stem Cell-Derived Dopaminergic Neurons
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Keyworddelim
13c Nmr; Cell Metabolism; Dopaminergic Neurons; Inducible Pluripotent Stem Cells; Kinase Substrates; Metabolomics; Microscopy; Mitochondria; Oxidative Phosphorylation; Parkinson'S Disease
Abstract
Parkinson's disease, PD, is a debilitating and incurable neurodegenerative disease that is particularly prevalent amongst the elderly here, in North America. In PD, a specific set of brain cells die. This causes severely impaired movement control in patients. Although the mechanism through which cells die is not fully understood, cellular metabolism has been widely implicated. A particular form of PD, called familial or early-onset PD, is a hereditary form of the disease that can be attributed to mutations in specific genes. Studying these mutants is essential to improve our understanding of PD as a whole. The loss of one protein, called PTEN-induced putative kinase 1, PINK1, is well known to cause early-onset forms of PD. Furthermore, this protein has been implicated in cellular metabolism, though how PINK1 contributes to this remains unknown. The reason that this question still remains unanswered can probably be attributed to the lack of good PD models. Neither animal models nor cells from other organs than the brain can fully recapitulate what occurs in human brain cells. However, recent advances in cell engineering now allow us to make human brain cells from skin cells harvested from PD patients. This provides us with a model in which to study PD that is much more relevant to what occurs in the human brain. Therefore, we will use this exciting new model to study defects in energy production and cellular metabolism in cells from patients lacking PINK1. By studying engineered human brain cells that lack PINK1, we expect to better our understanding of the metabolic defects that occur in PD and, ultimately, contribute to the development of better treatments for PD patients.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Scarffe, Leslie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
Direct Payment - $105,000 Grant (2011-12) | Canada Spends